Healthcare AI Acquisition Corp. shareholders approved an amendment authorizing the Company, by Board resolution, to extend its business-combination deadline from October 14, 2026 until October 14, 2027 on a month-to-month basis. Each monthly extension requires a deposit of $0.10 per non-redeemed Class A ordinary share into the trust account.
At the October 13, 2026 meeting, the proposal received 5,390,600 votes for and zero against, abstentions, or broker non-votes. On September 25, 2026, 5,520,078 ordinary shares were outstanding, comprising 5,520,077 Class A shares and one Class B share; proxies represented approximately 97.65% of the shares outstanding.
Healthcare AI Acquisition Corp. (HAIAF) asks shareholders to approve a month-to-month extension of its business-combination deadline from October 14, 2026, to October 14, 2027, with deposits of $0.10 per non-redeemed Public Share per month into the Trust Account. If approved, sponsor Atticus Ale LLC has indicated it will provide each monthly amount as an interest-free loan, repayable upon a business combination. The extension would allow more time for a proposed combination with Leading Group Limited; shareholders are not voting on that combination at this meeting.
As of September 29, 2026, the Trust Account held approximately $1,842,381.93, and the estimated redemption price was approximately $14.26 per Public Share. The virtual meeting is scheduled for October 13, 2026; approval requires a special resolution supported by at least two-thirds of holders voting in person or by proxy. If the proposal fails, HAIA says it will stop operations and redeem 100% of Public Shares as promptly as reasonably possible, but no more than 10 business days later, subject to available funds and applicable law. HAIA securities were suspended from Nasdaq on December 17, 2024, and currently trade OTC.
Healthcare AI Acquisition Corp. (symbol: HAIAF) is the issuer of record for a Form PRE 14A filing submitted to the SEC.
Healthcare AI Acquisition Corp. reported that shareholders approved extending the deadline to complete a business combination from October 14, 2025 on a month-to-month basis until October 14, 2026. For each monthly extension, the company will deposit $0.10 per non-redeemed public share into its trust account. In connection with the meeting, 23,033 shares were redeemed for approximately $292,422.64, or about $12.69 per share, to be paid from the trust. After these redemptions, the company has 5,520,077 Class A ordinary shares and one Class B share outstanding, and approximately $1,643,828.35 remains in its trust account.
Healthcare AI Acquisition Corp. filed a Form 12b-25 (NT 10-Q) stating it cannot file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 by the prescribed due date. The company cites difficulty completing and obtaining required financial and other information without unreasonable effort and expense.
The notification was signed by CFO Xiaocheng Peng on November 14, 2025.
Healthcare AI Acquisition Corp. filed its quarterly report for the period ended June 30, 2025. The company reported a Q2 net loss of $542,059, driven largely by a $495,079 unfavorable change in warrant liability fair value. For the six months, net loss was $616,178.
Total assets fell to $2,860,464, including $1,865,847 held in the trust account. Cash on hand was $212 with a working capital deficit of $2,503,403. Warrant liabilities increased to $657,185.
Redemptions continued: Class A shares subject to possible redemption decreased to 152,511 at a redemption value of $12.23 per share. The company obtained month‑to‑month extensions through October 14, 2025, supported by deposits, and disclosed substantial doubt about its ability to continue as a going concern if a business combination is not completed. As context, as of November 11, 2025, there were 5,543,110 Class A ordinary shares and 1 Class B share outstanding.
The company continues to pursue its Business Combination with Leading Group Limited, under which LEADING equity holders would receive 43,000,000 Holdco Class A shares and 500,000 Holdco shares would replace private placement warrants, subject to closing conditions.
Healthcare AI Acquisition Corp. (HAIAF) filed an 8-K/A to correct a scrivener error and report shareholder approval of an Extension Amendment Proposal. The change allows the company to extend its deadline to complete a business combination from October 14, 2025, on a month-to-month basis, up to October 14, 2026.
For each monthly extension, the company must deposit $0.10 per non-redeemed public share into its trust account. This structure preserves the SPAC’s optionality to continue pursuing a merger while compensating remaining public shareholders each month the timeline is extended.
Healthcare AI Acquisition Corp. reported shareholder approvals that allow the company to extend its deadline to complete a business combination on a month‑to‑month basis by depositing $0.10 per non‑redeemed public share into its trust account for each monthly extension. At the October 10, 2025 meeting, 5,315,600 votes were cast for the extension amendment, with 0 against and 0 abstain, representing 95.9% of the 5,543,111 shares entitled to vote as of September 10, 2025.
Shareholders also approved the ratification of Bush Associates CPA LLC as the independent registered public accounting firm for the fiscal year ending December 31, 2025, with the same vote totals.
Healthcare AI Acquisition Corp. disclosed two key updates related to its pending business combination with Leading Group Limited. The company postponed its annual general meeting, originally scheduled for October 6, 2025, to October 10, 2025 at 9:00 a.m. EST. It also changed the last date by which it can complete its business combination with Leading Group Limited, moving the deadline from March 14, 2026 to October 14, 2026. The filing reiterates that the company previously entered into a business combination agreement with Leading Partners Limited and Leading Group Limited to complete a merger-style transaction.
Healthcare AI Acquisition Corp. is calling an annual meeting on October 6, 2025 to ask shareholders to extend its SPAC deadline and avoid liquidation. The key proposal would move the business combination cut-off from October 14, 2025 to March 14, 2026, via month‑to‑month extensions funded by the sponsor at $0.10 per non‑redeemed Class A share per month, contributed as loans to the trust account.
Shareholders holding Public Shares may redeem in connection with this vote for about $12.53 per share, based on approximately $1,910,690.19 held in the trust account as of September 17, 2025. If the extension is not approved, the company will redeem 100% of Public Shares and dissolve. Investors are also being asked to ratify Bush & Associates CPA LLC as auditor and to approve a possible adjournment. HAIA has a signed business combination agreement with Leading Group Limited, under which Leading Group equityholders would receive 43,000,000 Holdco Class A ordinary shares and HAIA securities would convert into Holdco shares and warrants.